Published in J Abnorm Psychol on February 01, 2008
Early-stage visual processing abnormalities in high-functioning autism spectrum disorder (ASD). Transl Neurosci (2010) 0.81
EVENT-RELATED POTENTIAL STUDY OF ATTENTION REGULATION DURING ILLUSORY FIGURE CATEGORIZATION TASK IN ADHD, AUTISM SPECTRUM DISORDER, AND TYPICAL CHILDREN. J Neurother (2012) 0.80
Hippocampal temporal-parietal junction interaction in the production of psychotic symptoms: a framework for understanding the schizophrenic syndrome. Front Hum Neurosci (2012) 0.79
Neurophysiological correlates of configural face processing in schizotypy. Front Psychiatry (2014) 0.78
Progressive reduction of visual P300 amplitude in patients with first-episode schizophrenia: an ERP study. Schizophr Bull (2014) 0.76
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex. Nat Med (2011) 2.11
Modulation of anxiety circuits by serotonergic systems. Stress (2005) 1.81
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci (2004) 1.67
A key role for orexin in panic anxiety. Nat Med (2009) 1.63
Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Res (2002) 1.63
A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry (2010) 1.62
P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res (2008) 1.52
Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci (2008) 1.48
Interpretation of MMPI-A Scale 5 with female patients. Psychol Rep (2005) 1.39
Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr Bull (2007) 1.36
Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci (2008) 1.35
EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. Am J Psychiatry (2003) 1.35
Steady state responses: electrophysiological assessment of sensory function in schizophrenia. Schizophr Bull (2009) 1.33
Haloperidol impairs learning and error-related negativity in humans. J Cogn Neurosci (2004) 1.29
Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety (2010) 1.29
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety (2010) 1.24
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci (2003) 1.22
Eye-blink conditioning deficits indicate temporal processing abnormalities in schizophrenia. Schizophr Res (2009) 1.22
Event-related potential correlates of task switching and switch costs. Psychophysiology (2005) 1.19
Temporal processing dysfunction in schizophrenia. Brain Cogn (2008) 1.19
Steady state visual evoked potential abnormalities in schizophrenia. Clin Neurophysiol (2005) 1.17
Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J Biol Chem (2011) 1.15
Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport (2004) 1.12
Synchronization dynamics and evidence for a repertoire of network states in resting EEG. Front Comput Neurosci (2012) 1.12
Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides (2004) 1.11
Personality traits in schizophrenia and related personality disorders. Psychiatry Res (2005) 1.11
Orexin, stress, and anxiety/panic states. Prog Brain Res (2012) 1.11
Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res (2005) 1.11
Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol (2012) 1.11
Eye gaze and individual differences consistent with learned attention in associative blocking and highlighting. J Exp Psychol Learn Mem Cogn (2005) 1.09
Timing dysfunctions in schizophrenia span from millisecond to several-second durations. Brain Cogn (2009) 1.07
Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res Bull (2007) 1.06
Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure. J Psychopharmacol (2010) 1.06
Memory systems do not divide on consciousness: Reinterpreting memory in terms of activation and binding. Psychol Bull (2009) 1.06
Psychometrically matched visual-processing tasks in schizophrenia spectrum disorders. J Abnorm Psychol (2003) 1.05
The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav (2002) 1.05
Temporal discounting of rewards in patients with bipolar disorder and schizophrenia. J Abnorm Psychol (2011) 1.04
Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information? Schizophr Res (2009) 1.04
Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders. Schizophr Bull (2010) 1.04
The effect of selective attention on the gamma-band auditory steady-state response. Neurosci Lett (2007) 1.03
Neural pathways underlying lactate-induced panic. Neuropsychopharmacology (2007) 1.02
Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res (2011) 1.02
Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Eur J Pharmacol (2005) 1.02
Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography. Biol Psychiatry (2009) 1.02
Personality differences in schizophrenia are related to performance on neuropsychological tasks. J Nerv Ment Dis (2005) 1.02
A multimethod investigation of the behavioral activation system in bipolar disorder. J Abnorm Psychol (2008) 1.02
Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology (2007) 1.01
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today (2008) 1.00
Induction of Fos-immunoreactivity in the rat brain following disinhibition of the dorsomedial hypothalamus. Brain Res (2008) 0.99
The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress (2006) 0.99
Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology (2008) 0.99
Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin. J Psychopharmacol (2004) 0.98
The startle reflex in schizophrenia: habituation and personality correlates. Schizophr Res (2003) 0.97
A new statistical method for testing hypotheses of neuropsychological/MRI relationships in schizophrenia: partial least squares analysis. Schizophr Res (2002) 0.97
Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task. Brain Cogn (2009) 0.97
Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors. J Neurosci (2006) 0.96
Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res Bull (2006) 0.95
Event related brain potential evidence for preserved attentional set switching in schizophrenia. Schizophr Res (2007) 0.95
Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol Behav (2012) 0.95
Attention and emotional responses to sexual stimuli and their relationship to sexual desire. Arch Sex Behav (2007) 0.95
Eyeblink conditioning anomalies in bipolar disorder suggest cerebellar dysfunction. Bipolar Disord (2009) 0.95
Switch and maintenance of task set in schizophrenia. Schizophr Res (2006) 0.95
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia. Int J Neuropsychopharmacol (2009) 0.95
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypy. Am J Psychiatry (2006) 0.95
Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Res (2008) 0.94